Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
REGN
REGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
REGN News
Regeneron Projects $127M R&D Charge for Q2 2026
2d ago
seekingalpha
Alnylam Pharmaceuticals Shares Drop 24%, Yet Optimism Persists
6d ago
Fool
Alnylam Pharmaceuticals Reports Strong Q1 Performance
6d ago
NASDAQ.COM
Intellia Therapeutics Shares Surge 83% Amid Strong Clinical Progress
6d ago
Fool
Supreme Court Rulings Have Significant Implications
Jun 30 2026
Newsfilter
Supreme Court Rulings Have Far-Reaching Implications
Jun 30 2026
CNBC
FDA Selects Seven Drug Companies for PreCheck Pilot Program
Jun 29 2026
seekingalpha
ADMA Biologics Shows Promising Profitability Outlook
Jun 29 2026
NASDAQ.COM
SpaceX's $2 Trillion Valuation Faces Significant Hurdles Ahead
Jun 29 2026
Fool
Parabilis IPO Outperforms SpaceX's Debut
Jun 28 2026
NASDAQ.COM
Parabilis Medicines IPO Surges 58%, Outpacing SpaceX
Jun 28 2026
Fool
Regeneron's Cemdisiran Marketing Applications Accepted by U.S. and European Regulators
Jun 23 2026
seekingalpha
Regeneron and Amgen's Promising Weight Loss Candidates
Jun 23 2026
NASDAQ.COM
Emerging Stars in Weight Loss: Regeneron and Amgen
Jun 23 2026
Fool
AbbVie Acquires Apogee Therapeutics for $10.9 Billion
Jun 22 2026
Yahoo Finance
AbbVie Launches $11 Billion Bid for Apogee Therapeutics
Jun 22 2026
Fool
Show More News
